The pill with the imprint E 318 is a prescription generic medication manufactured by Epic Pharma, LLC. It is widely prescribed for the management of primary hypertension (high blood pressure) and to reduce edema (fluid retention) caused by conditions like congestive heart failure, liver cirrhosis, or renal dysfunction.
Pill Identification
Accurately identifying oral medications is crucial to preventing dosing errors. The E 318 pill features highly specific physical attributes:
- Imprint: Stamped with a distinct E on one side and the number 318 on the reverse side.
- Color: Light peach to pinkish orange.
- Shape: Round.
- Active Ingredient & Strength: Each tablet contains exactly 12.5 mg of Hydrochlorothiazide (HCTZ).
- Therapeutic Class: Thiazide diuretic (“water pill”).
Mechanism of Action
The E 318 pill exerts its cardiovascular and diuretic effects directly within the kidneys. It acts primarily on the distal convoluted tubule of the nephron (the functional filtering unit of the kidney):
- Inhibition of Solute Reabsorption: Hydrochlorothiazide blocks the symporter (co-transporter) protein on the luminal membrane of the tubule. By binding to this transporter, it physically prevents the kidney from reabsorbing sodium and chloride ions back into the bloodstream.
- Diuresis & Natriuresis: Because sodium and chloride remain trapped inside the kidney tubules, they create an osmotic gradient that pulls water along with them. This leads to increased excretion of water, sodium, chloride, and potassium in the urine.
- Blood Pressure Reduction:
- Short-term: The sudden drop in blood volume decreases cardiac output, lowering systemic blood pressure.
- Long-term: Even after blood volumes normalize slightly over weeks of treatment, HCTZ causes a direct background relaxation of peripheral blood vessels (vasodilation), reducing overall vascular resistance.
Standard Dosage & Administration
The 12.5 mg strength represented by the E 318 pill is frequently utilized as a low-dose starting option, either alone or combined with other antihypertensive medications.
- Hypertension: The standard adult starting dose is 12.5 mg to 25 mg once daily. If blood pressure remains elevated, a physician may increase the dose up to 50 mg daily, taken either as a single dose or divided into two doses.
- Edema: The typical adult dosage ranges from 25 mg to 100 mg daily, taken in single or divided doses. Some clinical protocols utilize intermittent dosing (e.g., taking the pill every other day) to minimize electrolyte imbalances.
- Administration Guidelines: It should ideally be taken in the morning with or without food. Taking this medication late in the afternoon or evening can cause structural sleep disruptions due to nocturnal urination (nocturia).
Side Effects
Because hydrochlorothiazide alters fluid balances and systemic electrolyte levels, it can precipitate various metabolic and systemic side effects.
Common Side Effects
- Frequent urination and mild dehydration
- Dizziness or lightheadedness, particularly when standing up quickly (orthostatic hypotension)
- Mild headache or blurred vision
- Loss of appetite, mild nausea, or stomach cramping
- Increased sensitivity to sunlight (photosensitivity)
Serious Side Effects
Seek emergency medical evaluation if any of these severe adverse reactions manifest:
- Profound Hypokalemia (Low Potassium): Indicated by severe muscle weakness, muscle spasms, cardiac arrhythmias, or extreme fatigue.
- Acute Hyponatremia (Low Sodium): Manifests as severe confusion, deep lethargy, persistent headaches, seizures, or swelling in the brain.
- Hyperuricemia (High Uric Acid): Hydrochlorothiazide blocks uric acid clearance, which can trigger painful, acute flare-ups of gout in susceptible individuals.
- Severe Metabolic Shifts: Can cause unexplained elevations in blood sugar (hyperglycemia, a risk factor for individuals with Type 2 diabetes) and adverse alterations in lipid profiles.
Precautions & Warnings
Absolute Contraindications
- Anuria: The E 318 pill must never be given to individuals whose kidneys have completely stopped producing urine, as the drug cannot function and can accumulate to toxic levels.
- Sulfonamide Allergy: Because hydrochlorothiazide is structurally derived from sulfonamides, individuals with known severe allergies to “sulfa” drugs may experience severe cross-reactive allergic events.
Clinical Warnings
- Warning: Electrolyte Depletion
- Continuous therapy with the E 318 pill requires periodic laboratory monitoring of serum electrolytes (especially potassium, sodium, and magnesium). Hypokalemia induced by thiazides can drastically increase the cardiac toxicity of medications like digitalis glycosides.
- Impaired Renal and Hepatic Function: Patients suffering from advanced renal disease require meticulous monitoring, as the drug can precipitate acute uremia (accumulation of nitrogenous waste). If renal impairment worsens drastically during use, the medication should be withheld.
- Lupus Erythematosus: Thiazide diuretics have been documented to trigger or exacerbate systemic lupus erythematosus (SLE) flare-ups.
Major Drug Interactions
- Lithium: Hydrochlorothiazide slows down the renal clearance of lithium. Co-administration dramatically increases the risk of life-threatening lithium toxicity.
- NSAINs (e.g., Ibuprofen, Naproxen): Non-steroidal anti-inflammatory drugs can restrict intrarenal blood flow, blunting both the diuretic and blood-pressure-lowering effectiveness of the E 318 tablet.
- Other Antihypertensive Agents: Combining HCTZ with ACE inhibitors, ARBs, or beta-blockers provides synergistic blood pressure control but significantly increases the risk of initial dizziness or profound hypotension.